Pacific Biosciences Of California (PACB) Finished Goods (2011 - 2026)

Pacific Biosciences Of California has reported Finished Goods for 16 years, with the latest figure at $17.8 million in Q1 2026.

• For the quarter ending Q1 2026, Finished Goods rose 32.83% year-over-year to $17.8 million; the trailing twelve-month figure through Mar 2026 stood at $17.8 million (up 32.83% YoY), and the FY2025 full-year result was $15.7 million, up 11.56% from the prior year.
• Finished Goods for Q1 2026 stood at $17.8 million, up from $15.7 million in the prior quarter.
• The five-year high for Finished Goods was $19.8 million in Q2 2023, with the low at $7.9 million in Q2 2022.
• Average Finished Goods over 5 years is $14.6 million, with a median of $15.7 million recorded in 2025.
• Year-over-year, Finished Goods jumped 151.65% in 2023 and slipped 18.18% in 2025.
• Tracing PACB's Finished Goods over 5 years: stood at $12.2 million in 2022, then grew by 29.28% to $15.7 million in 2023, then declined by 10.57% to $14.1 million in 2024, then advanced by 11.56% to $15.7 million in 2025, then grew by 13.55% to $17.8 million in 2026.
• The last three Finished Goods figures came in at $17.8 million (Q1 2026), $15.7 million (Q4 2025), and $16.4 million (Q3 2025), per Business Quant data.

Peer Comparison